Guangzhou Xiangxue Pharmaceutical Co.,Ltd. Posted 8.3 Million Yuan Net Profit in First Quarter of 2023

Guangzhou Xiangxue Pharmaceutical Co.,Ltd. (广州市香雪制药股份有限公司) (300147.SZ) reported a net profit of 8.3 million yuan in the first quarter of 2023, reversing a net loss of 41.9 million yuan for the same period in the previous year.

Meanwhile, the company posted 588.7 million yuan in revenue, down 4.1% year-on-year.

At the end of the reporting period, it had 9.3 billion yuan in total assets and 6.5 billion yuan in total liabilities, with a liability-to-asset ratio of 69.7%.